RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer

Oncogene

Volumn 26, Issue 5, 2007, Pages 683-700

  Bignone, P A ^a   Lee, K Y ^a   Liu, Y ^a   Emilion, G ^a   Finch, J ^a   Soosay, A E R ^a   Charnock, F M L ^a   Beck, S ^b   Dunham, I ^b   Mungall, A J ^b   Ganesan, T S ^a,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chromosome 6q27; Ovarian cancer; RPS6KA2; Tumour suppressor gene

Indexed keywords

CELL CYCLE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RNA; S6 KINASE; TUMOR SUPPRESSOR PROTEIN;

ALLELE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHROMOSOME 6Q; COLONY FORMATION; EPITHELIUM; FEMALE; GENE DELETION; GENE EXPRESSION; HOMOZYGOSITY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; START CODON; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; AMINO ACID SEQUENCE; APOPTOSIS; CARCINOMA, ENDOMETRIOID; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; CYSTADENOCARCINOMA, SEROUS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOPRECIPITATION; LOSS OF HETEROZYGOSITY; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA INTERFERENCE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33846849470     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209827     Document Type: Article

References (69)

1. Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC. (2003). LOT1 (PLAG1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem 278: 6041-6049.
2. Acquati F, Morelli C, Cinquetti R, Bianchi MG, Porrini D, Varesco L et al. (2001). Cloning and characterisation of a senescence inducing and class II tumour suppressor gene in ovarian carcinoma at chromosome region 6q27. Oncogene 20: 980-988.
3. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M et al. (2004). A large-scale RNAi screen in human cells identifies new components of the P53 pathway. Nature 428: 431-437.
4. Bjorbaek C, Zhao Y, Moller DE. (1995). Divergent functional roles for P90rsk kinase domains. J Biol Chem 270: 18848-18852.
5. Bothos J, Tuttle RL, Ottey M, Luca FC, Halazonetis TD. (2005). Human lats1 is a mitotic exit networkk inase. Cancer Res 65: 6568-6575.
6. Bruning JC, Gillette JA, Zhao Y, Bjorbaeck C, Kotzka J, Knebel B et al. (2000). Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc Natl Acad Sci USA 97: 2462-2467.
7. Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M et al. (2004). Epigenetic and genetic loss of HIC1 function accentuates the role of P53 in tumorigenesis. Cancer Cell 6: 387-398.
8. Chenevix-Trench G, Kerr J, Hurst T, Shih YC, Purdie D, Bergman L et al. (1997). Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations. Genes Chromosomes Cancer 18: 75-83.
9. Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR et al. (1998). Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Exp Cell Res 238: 439-449.
10. Cooke IE, Cox SA, Shelling AN, Le Meuth VG, Spurr NK, Ganesan TS. (1996a). An integrated genetic map of chromosome 6. Mamm Genome 7: 157-159.
11. Cooke IE, Shelling AN, Le Meuth VG, Charnock ML, Ganesan TS. (1996b). Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosomes Cancer 15: 223-233.
12. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P et al. (2005). A survey of homozygous deletions in human cancer genomes. Proc Natl Acad Sci USA 102: 4542-4547.
13. Douville E, Downward J. (1997). EGF induced Sos phosphorylation in PC12 cells involves P90 Rsk-2. Oncogene 15: 373-383.
14. Dufresne SD, Bjorbaek C, El-Haschimi K, Zhao Y, Aschenbach WG, Moller DE et al. (2001). Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from P90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 21: 81-87.
15. Dummler BA, Hauge C, Silber J, Yntema HG, Kruse LS, Kofoed B et al. (2005). Functional characterization of human Rsk4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem 280: 13304-13314.
16. Esteller M. (2002). CpG Island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21: 5427-5440.
17. Feinberg AP, Tycko B. (2004). The history of cancer epigenetics. Nat Rev Cancer 4: 143-153.
18. Frodin M, Gammeltoft S. (1999). Role and regulation of 90 kDa ribosomal S6 kinase (Rsk) in signal transduction. Mol Cell Endocrinol 151: 65-77.
19. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW et al. (1992). A Genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831.
20. Fuchtner C, Emma DA, Manetta A, Gamboa G, Bernstein R, Liao SY. (1993). Characterization of a human ovarian carcinoma cell line: UCI 101. Gynecol Oncol 48: 203-209.
21. Goldmit M, Bergman Y. (2004). Monoallelic gene expression: a repertoire of recurrent themes. Immunol Rev 200: 197-214.
22. Horgan AM, Stork PJ. (2003). Examining the mechanism of Erk nuclear translocation using green fluorescent protein. Exp Cell Res 285: 208-220.
23. Jirtle RL. (1999). Genomic imprinting and cancer. Exp Cell Res 248: 18-24.
24. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H, Ropers HH. (1993). The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nat Genet 5: 74-78.
25. Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, Uehara Y. (1997). Induction of P27kip1 degradation and anchorage independence by Ras through the map kinase signaling pathway. Oncogene 15: 629-637.
26. Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
27. Laval S, Butler R, Shelling AN, Hanby AM, Poulsom R, Ganesan TS. (1994). Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth Differ 5: 1173-1183.
28. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. (1996). Cyclin D1 expression is regulated positively by the P42/P44mapkand negatively by the P38/HOGMAPK pathway. J Biol Chem 271: 20608-20616.
29. Li LC, Dahiya R. (2002). MethPrimer: designing primers for methylation Pcrs. Bioinformatics 18: 1427-1431.
30. Lin H, Morin PJ. (2001). A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene. Cancer Lett 173: 63-70.
31. Liu Y, Dodds P, Emilion G, Mungall AJ, Dunham I, Beck S et al. (2002a). The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genet 3: 20.
32. Liu Y, Emilion G, Mungall AJ, Dunham I, Beck S, Le Meuth-Metzinger VG et al. (2002b). Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. Oncogene 21: 387-399.
33. Liu Y, Ganesan TS. (2002). Tumour suppressor genes in sporadic epithelial ovarian cancer. Reproduction 123: 341-353.
34. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH et al. (2003). Allelic variation in gene expression is common in the human genome. Genome Res 13: 1855-1862.
35. Luedi PP, Hartemink AJ, Jirtle RL. (2005). Genome-wide prediction of imprinted murine genes. Genome Res 15: 875-884.
36. Modesitt SC, Ramirez P, Zu Z, Bodurka-Bevers D, Gershenson D, Wolf JK. (2001). In vitro and in vivo adenovirus-mediated P53 and P16 tumor suppressor therapy in ovarian cancer. Clin Cancer Res 7: 1765-1772.
37. Moller DE, Xia CH, Tang W, Zhu AX, Jakubowski M. (1994). Human rsk isoforms: cloning and characterization of tissue-specific expression. Am J Physiol 266: C351-C359.
38. Morison IM, Ramsay JP, Spencer HG. (2005). A census of mammalian imprinting. Trends Genet 21: 457-465.
39. Myers AP, Corson LB, Rossant J, Baker JC. (2004). Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-Ras-extracellular signal-regulated kinase signaling. Mol Cell Biol 24: 4255-4266.
40. Nikaido I, Saito C, Mizuno Y, Meguro M, Bono H, Kadomura M et al. (2003). Discovery of imprinted transcripts in the mouse transcriptome using large-scale expression profiling. Genome Res 13: 1402-1409.
41. Ohlsson R, Tycko B, Sapienza C. (1998). Monoallelic expression: 'there can only be one'. Trends Genet 14: 435-438.
42. Ohtani N, Yamakoshi K, Takahashi A, Hara E. (2004). The P16ink4a-Rb pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51: 146-153.
43. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time Rt-Pcr. Nucleic Acids Res 29: e45.
44. Pineau P, Marchio A, Cordina E, Tiollais P, Dejean A. (2003). Homozygous deletions scanning in tumor cell lines detects previously unsuspected loci. Int J Cancer 106: 216-223.
45. Reik W, Lewis A. (2005). Co-evolution of X-chromosome inactivation and imprinting in mammals. Nat Rev Genet 6: 403-410.
46. Rougeulle C, Glatt H, Lalande M. (1997). The angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet 17: 14-15.
47. Saito S, Saito H, Koi S, Sagae S, Kudo R, Saito J et al. (1992). Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res 52: 5815-5817.
48. Sano Y, Shimada T, Nakashima H, Nicholson RH, Eliason JF, Kocarek TA et al. (2001). Random monoallelic expression of three genes clustered within 60 kb of mouse T complex genomic DNA. Genome Res 11: 1833-1841.
49. Schinelli S, Zanassi P, Paolillo M, Wang H, Feliciello A, Gallo V. (2001). Stimulation of endothelin B receptors in astrocytes induces camp response element-binding protein phosphorylation and c-Fos expression via multiple mitogenactivated protein kinase signaling pathways. J Neurosci 21: 8842-8853.
50. Schreiber M, Muller WJ, Singh G, Graham FL. (1999). Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors P16ink4a, P18ink4c, P19ink4d, P21(Waf1/Cip1) and P27kip1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity. Oncogene 18: 1663-1676.
51. Shelling AN, Cooke IE, Ganesan TS. (1995). The genetic analysis of ovarian cancer. Br. J. Cancer. 72: 521-527.
52. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T et al. (2002). Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465-4470.
53. Suzuki Y, Yamashita R, Sugano S, Nakai K. (2004). DBTSS, DataBase of Transcriptional Start Sites: progress report 2004. Nucleic Acids Res 32: D78-D81.
54. Teng DH, Perry III WL, Hogan JK, Baumgard M, Bell R, Berry S et al. (1997). Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 57: 4177-4182.
55. Tibiletti MG, Bernasconi B, Furlan D, Riva C, Trubia M, Buraggi G et al. (1996). Early involvement of 6q in surface epithelial ovarian tumors. Cancer Res 56: 4493-4498.
56. Tibiletti MG, Sessa F, Bernasconi B, Cerutti R, Broggi B, Furlan D et al. (2000). A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast. Clin Cancer Res 6: 1422-1431.
57. Tibiletti MG, Trubia M, Ponti E, Sessa L, Acquati F, Furlan D et al. (1998). Physical map of the D6S149-D6S193 region on chromosome 6q27 and its involvement in benign surface epithelial ovarian tumours. Oncogene 16: 1639-1642.
58. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I et al. (1996). Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384: 567-570.
59. Trubia M, Sessa L, Taramelli R. (1997). Mammalian Rh/T2/S-glycoprotein ribonuclease family genes: cloning of a human member located in a region of chromosome 6 (6q27) frequently deleted in human malignancies. Genomics 42: 342-344.
60. Tsao SW, Mok SC, Fey EG, Fletcher JA, Wan TS, Chew EC et al. (1995). Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (Hpv-E6e7 Orfs). Exp Cell Res 218: 499-507.
61. Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK et al. (1995). P53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577.
62. Wilkinson MG, Millar JB. (2000). Control of the eukaryotic cell cycle by map kinase signaling pathways. FASEB J 14: 2147-2157.
63. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by P21cip1. Mol Cell Biol 17: 5598-5611.
64. Xing J, Kornhauser JM, Xia Z, Thiele EA, Greenberg ME. (1998). Nerve growth factor activates extracellular signal-regulated kinase and P38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol Cell Biol 18: 1946-1955.
65. Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, Chelly J et al. (1999). A novel ribosomal S6-kinase (Rsk4; Rps6ka6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62: 332-343.
66. Yoo LI, Chung DC, Yuan J. (2002). LKB1 - a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer 2: 529-535.
67. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y et al. (1999). NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214-219.
68. Zeniou M, Ding T, Trivier E, Hanauer A. (2002). Expression analysis of Rsk gene family members: the Rsk2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum Mol Genet 11: 2929-2940.
69. Zhao Y, Bjorbaek C, Weremowicz S, Morton CC, Moller DE. (1995). Rsk3 encodes a novel Pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 15: 4353-4363.